Rawat Mohit 4
4 · Fusion Pharmaceuticals Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
Rawat Mohit
President and CBO
Transactions
- Award
Common Stock
2023-08-31+12,843→ 12,843 total - Award
Stock Option (Right to Buy)
2024-01-04+135,500→ 135,500 totalExercise: $8.44Exp: 2034-01-04→ Common Stock (135,500 underlying) - Award
Restricted Stock Units
2024-01-04+81,300→ 81,300 total→ Common Stock (81,300 underlying)
Footnotes (4)
- [F1]These shares were purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan.
- [F2]This option vests in 48 equal monthly installments beginning on February 4, 2024.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock of Fusion Pharmaceuticals Inc. for no consideration.
- [F4]The restricted stock units vest in six equal installments on each of July 4, 2024, January 4, 2025, July 4, 2025, January 4, 2026, July 4, 2026 and January 4, 2027.